191 related articles for article (PubMed ID: 35692765)
1. Clinical Outcomes and Prognostic Analysis of 101 Patients of Central Neurocytoma: A 10-Year Treatment Experience at a Single Institution.
Xie Q; Xie B; Ou L; Wang M; Tang Z; He Y; Yang X; Hong J; Lyu Z; Wei R
Front Oncol; 2022; 12():881460. PubMed ID: 35692765
[TBL] [Abstract][Full Text] [Related]
2. Comparison of surgery with or without adjuvant radiotherapy in treating central neurocytoma: a single-center retrospective real-world study.
She L; Deng D; Su L; Liu C
J Neurooncol; 2022 Nov; 160(2):455-462. PubMed ID: 36307664
[TBL] [Abstract][Full Text] [Related]
3. Clinicoradiological features and surgical outcomes of primary intracranial medulloepitheliomas: a single-center experience and pooled analysis of individual patient data.
Li D; Hao SY; Wang L; Li GL; Wang JM; Wu Z; Zhang LW; Zhang JT; Jia W
J Neurosurg; 2018 Jul; ():1-15. PubMed ID: 29979121
[TBL] [Abstract][Full Text] [Related]
4. Surgical management and long-term outcomes of intracranial giant cell tumors: a single-institution experience with a systematic review.
Weng JC; Li D; Wang L; Wu Z; Wang JM; Li GL; Jia W; Zhang LW; Zhang JT
J Neurosurg; 2018 Oct; 131(3):695-705. PubMed ID: 30497189
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma.
Chen YD; Li WB; Feng J; Qiu XG
Radiat Oncol; 2014 Nov; 9():242. PubMed ID: 25373333
[TBL] [Abstract][Full Text] [Related]
6. Clinical prognostic factors for central neurocytoma and subgroup analysis of different treatment measures: A SEER database-based retrospective analysis from 2003 to 2019.
Zhang Z; Yu J; Zhang C; Pang X; Wei Y; Lv Q; Chen H; Jin X; Zhan R
Front Oncol; 2022; 12():1014506. PubMed ID: 36686752
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features, Treatment, and Long-term Outcomes of Central Neurocytoma: A 20-Year Experience at a Single Center.
Wang M; Zhou P; Zhang S; Liu X; Lv L; Wang Z; Ye F; Wang X; Jiang S
World Neurosurg; 2018 Jan; 109():e59-e66. PubMed ID: 28958923
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.
Oh MC; Ivan ME; Sun MZ; Kaur G; Safaee M; Kim JM; Sayegh ET; Aranda D; Parsa AT
Neuro Oncol; 2013 Feb; 15(2):208-15. PubMed ID: 23229996
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.
Imber BS; Braunstein SE; Wu FY; Nabavizadeh N; Boehling N; Weinberg VK; Tihan T; Barnes M; Mueller S; Butowski NA; Clarke JL; Chang SM; McDermott MM; Prados MD; Berger MS; Haas-Kogan DA
J Neurooncol; 2016 Jan; 126(1):193-200. PubMed ID: 26493740
[TBL] [Abstract][Full Text] [Related]
10. Individual Treatment Decisions for Central Neurocytoma.
Han S; Yang Z; Yang Y; Qi X; Yan C; Yu C
Front Neurol; 2020; 11():834. PubMed ID: 32922351
[No Abstract] [Full Text] [Related]
11. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of adjuvant radiotherapy in the intracranial hemangiopericytoma.
Jeon SH; Park SH; Kim JW; Park CK; Paek SH; Kim IH
J Neurooncol; 2018 May; 137(3):567-573. PubMed ID: 29327171
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and treatment outcomes of central neurocytomas: clinical interrogation based on a single center experience.
Byun J; Hong SH; Yoon MJ; Kwon SM; Cho YH; Kim JH; Kim CJ
J Neurooncol; 2018 Dec; 140(3):669-677. PubMed ID: 30225773
[TBL] [Abstract][Full Text] [Related]
14. The role of postoperative radiotherapy for the treatment of gangliogliomas.
Rades D; Zwick L; Leppert J; Bonsanto MM; Tronnier V; Dunst J; Schild SE
Cancer; 2010 Jan; 116(2):432-42. PubMed ID: 19908258
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
16. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas.
Schoenfeld A; Pekmezci M; Barnes MJ; Tihan T; Gupta N; Lamborn KR; Banerjee A; Mueller S; Chang S; Berger MS; Haas-Kogan D
J Neurooncol; 2012 May; 108(1):133-9. PubMed ID: 22350375
[TBL] [Abstract][Full Text] [Related]
17. Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study.
Song D; Xu D; Han H; Gao Q; Zhang M; Wang F; Wang G; Guo F
Front Oncol; 2021; 11():787962. PubMed ID: 34926303
[TBL] [Abstract][Full Text] [Related]
18. MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas.
Kaur G; Kane AJ; Sughrue ME; Oh M; Safaee M; Sun M; Tihan T; McDermott MW; Berger MS; Parsa AT
J Clin Neurosci; 2013 Jan; 20(1):89-93. PubMed ID: 23137668
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy after surgery for benign cerebral meningioma.
Soyuer S; Chang EL; Selek U; Shi W; Maor MH; DeMonte F
Radiother Oncol; 2004 Apr; 71(1):85-90. PubMed ID: 15066300
[TBL] [Abstract][Full Text] [Related]
20. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A
Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
